These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 21901982)

  • 1. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate.
    Singh KH; Shinde UA
    Curr Drug Deliv; 2010 Jul; 7(3):244-51. PubMed ID: 20497099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
    Aburahma MH; Mahmoud AA
    AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA; Aminabhavi TM
    J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
    Sharma PK; Chauhan MK
    Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H; Oh M; Allen C; Kumacheva E
    Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
    Bhagav P; Upadhyay H; Chandran S
    AAPS PharmSciTech; 2011 Dec; 12(4):1087-101. PubMed ID: 21879393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
    Kao HJ; Lin HR; Lo YL; Yu SP
    J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
    Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
    Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
    Luo Y; Zhang B; Whent M; Yu LL; Wang Q
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34.
    Zhao SH; Wu XT; Guo WC; Du YM; Yu L; Tang J
    Int J Pharm; 2010 Jun; 393(1-2):268-72. PubMed ID: 20435115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
    Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK
    Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.